Mina Waraya

649 total citations
30 papers, 514 citations indexed

About

Mina Waraya is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mina Waraya has authored 30 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Mina Waraya's work include Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (8 papers) and RNA modifications and cancer (6 papers). Mina Waraya is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (8 papers) and RNA modifications and cancer (6 papers). Mina Waraya collaborates with scholars based in Japan, United States and Israel. Mina Waraya's co-authors include Keishi Yamashita, Hiroshi Katoh, Masahiko Watanabe, Hiroshi Nishimiya, Akira Ema, Mariko Kikuchi, Yoshimasa Kosaka, Masahiko Watanabe, Hiroshi Kawamata and Akira Ooki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Mina Waraya

29 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mina Waraya Japan 15 279 196 124 122 79 30 514
Artit Jinawath Thailand 12 221 0.8× 133 0.7× 97 0.8× 84 0.7× 68 0.9× 32 451
Laura López-Vicente Spain 4 265 0.9× 166 0.8× 69 0.6× 88 0.7× 66 0.8× 4 480
Kshitij S. Arora United States 13 284 1.0× 254 1.3× 176 1.4× 158 1.3× 113 1.4× 37 684
Joshua N. Honeyman United States 10 289 1.0× 128 0.7× 131 1.1× 182 1.5× 113 1.4× 21 615
Malti Kshirsagar United States 9 201 0.7× 218 1.1× 94 0.8× 176 1.4× 151 1.9× 9 603
Rebecca J. Wolsky United States 8 223 0.8× 121 0.6× 61 0.5× 89 0.7× 88 1.1× 21 624
Su Mei Cao China 6 173 0.6× 281 1.4× 140 1.1× 137 1.1× 86 1.1× 19 586
Luísa Matos do Canto Brazil 15 286 1.0× 214 1.1× 58 0.5× 187 1.5× 61 0.8× 34 521

Countries citing papers authored by Mina Waraya

Since Specialization
Citations

This map shows the geographic impact of Mina Waraya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Waraya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Waraya more than expected).

Fields of papers citing papers by Mina Waraya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Waraya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Waraya. The network helps show where Mina Waraya may publish in the future.

Co-authorship network of co-authors of Mina Waraya

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Waraya. A scholar is included among the top collaborators of Mina Waraya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Waraya. Mina Waraya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waraya, Mina, Takafumi Sangai, Ryo Kawata, et al.. (2025). Hidden SVA retrotransposon insertion in BRCA1 revealed by nanopore targeted sequencing causes hereditary breast and ovarian cancer. Journal of Human Genetics. 70(10). 503–508.
2.
Waraya, Mina, et al.. (2023). [Decision-Making Regarding Adjuvant Therapy for Hormone Receptor-Positive, HER2-Negative Early Breast Cancer].. PubMed. 50(2). 230–232. 1 indexed citations
3.
Nakamura, Takatoshi, et al.. (2021). Examination of the efficacy of olanexidine gluconate for surgical site infections in colorectal cancer elective surgery. Journal of Infection and Chemotherapy. 27(12). 1729–1734. 4 indexed citations
4.
Kosaka, Yoshimasa, et al.. (2019). Historical progress of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual in patients with breast cancer. Translational Cancer Research. 8(3). 719–721. 18 indexed citations
5.
Tanaka, Yôko, Yoshimasa Kosaka, Mina Waraya, et al.. (2019). Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer. Anticancer Research. 39(5). 2289–2298. 8 indexed citations
6.
Kosaka, Yoshimasa, Yôko Tanaka, Mariko Kikuchi, et al.. (2018). Lymph node metastasis and high serum CEA are�important prognostic factors in hormone receptor positive and HER2 negative breast cancer. Molecular and Clinical Oncology. 9(5). 566–574. 7 indexed citations
7.
Kikuchi, Mariko, Hiroshi Katoh, Mina Waraya, et al.. (2016). Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer. Cancer Letters. 384. 70–78. 28 indexed citations
8.
Ushiku, Hideki, Keishi Yamashita, Hiroshi Kawamata, et al.. (2016). Homeobox-Only Protein Expression Is a Critical Prognostic Indicator of Pancreatic Neuroendocrine Tumor and Is Regulated by Promoter DNA Hypermethylation. Pancreas. 45(9). 1255–1262. 19 indexed citations
9.
Waraya, Mina, Keishi Yamashita, Mariko Kikuchi, et al.. (2016). Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. PLoS ONE. 11(1). e0144862–e0144862. 29 indexed citations
10.
Nakamura, Kazunori, Keishi Yamashita, Hiromichi Sawaki, et al.. (2015). Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC.. PubMed. 35(3). 1411–21. 22 indexed citations
11.
Waraya, Mina, Keishi Yamashita, Akira Ema, et al.. (2015). Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype. PLoS ONE. 10(10). e0139902–e0139902. 14 indexed citations
13.
Nishimiya, Hiroshi, Yoshimasa Kosaka, Keishi Yamashita, et al.. (2014). Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up.. PubMed. 34(1). 259–68. 13 indexed citations
14.
Tanino, Hirokazu, Yoshimasa Kosaka, Mariko Kikuchi, et al.. (2014). The Safety of Concentrated Trastuzumab in 100 ml of Saline Solution for Administration to Patients with HER2-Positive Breast Cancer: A Phase 1 Study. Chemotherapy. 60(1). 1–6. 2 indexed citations
15.
Yamashita, Keishi, Mina Waraya, Myoung Sook Kim, et al.. (2014). Detection of Methylated CDO1 in Plasma of Colorectal Cancer; A PCR Study. PLoS ONE. 9(12). e113546–e113546. 25 indexed citations
16.
Ema, Akira, Mina Waraya, Keishi Yamashita, et al.. (2014). Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer. Cancer Medicine. 4(1). 90–100. 24 indexed citations
17.
Waraya, Mina, Yoshimasa Kosaka, Mariko Kikuchi, et al.. (2012). [Efficacy and safety of lidocaine hydrochloride jelly for the treatment of pain caused by breast cancer metastases to the skin].. PubMed. 39(12). 2063–5. 1 indexed citations
18.
Katoh, Hiroshi, Keishi Yamashita, Mina Waraya, et al.. (2012). Epigenetic Silencing of HOPX Promotes Cancer Progression in Colorectal Cancer. Neoplasia. 14(7). 559–IN6. 59 indexed citations
19.
Waraya, Mina, Keishi Yamashita, Hiroshi Katoh, et al.. (2012). Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis. BMC Cancer. 12(1). 397–397. 36 indexed citations
20.
Waraya, Mina, Keishi Yamashita, Hiroyuki Katagiri, et al.. (2009). Preoperative Serum CA19-9 and Dissected Peripancreatic Tissue Margin as Determiners of Long-Term Survival in Pancreatic Cancer. Annals of Surgical Oncology. 16(5). 1231–1240. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026